Current Opinion in Nephrology and Hypertension was launched in 1992. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of nephrology and hypertension is divided into 12 sections that are each reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Nancy J. Brown
Nancy J. Brown is Hugh Jackson Morgan Professor of Medicine and Pharmacology, and Chair and Physician-in-Chief of the Department of Medicine at Vanderbilt University, USA. Dr Brown studies how drugs that affect the renin-angiotensin-aldosterone, kallikrein-kinin, and eicosanoid systems alter the risk of thrombosis and fibrosis. Dr Brown is an active member of the American Heart Association Council for High Blood Pressure Research and the American Society of Hypertension and serves on the Advisory Council for NHLBI. Her honors include the American Society of Hypertension Young Scholar Award, American Federation for Clinical Research Outstanding Investigator Award, the Vanderbilt Grant Liddle Award, the E.K. Frey- E. Werle Foundation Promotion Prize, the AHA Harriet Dustan award, membership in the American Society for Clinical Investigation and in the Association of American Physicians. She is also a Fellow of the American Association for the Advancement of Science and a member of the National Academy of Medicine.
Bertrand L. Jaber
Dr Bertrand L. Jaber currently serves as Vice Chair for Quality Affairs in the Department of Medicine at St. Elizabeth's Medical Center in Boston, MA, USA, and is a Professor of Medicine at Tufts University School of Medicine, USA. He holds a Master of Science in Clinical Research from the Sackler School of Graduate Biomedical Sciences, Tufts University. Dr Jaber has extensive expertise in dialysis device-related research, translational and outcomes research in acute kidney injury. He has also made important contributions to evidence-based medicine by conducting systematic reviews and meta-analyses on the prevention and treatment of acute kidney injury and chronic kidney disease.
Dr Jaber received his medical degree from St. Joseph University School of Medicine, Beirut, Lebanon, and completed a residency in Internal Medicine at Carney Hospital, Boston, MA, and a clinical and research fellowship in nephrology at Tufts New England Medical Center, Boston, MA. He has served as Chair of the Acute Kidney Injury Advisory Group for the American Society of Nephrology. He is a former member of the Renal Disease and Detoxification Committee of the Association for the Advancement of Medical Instrumentation, the Kidney Disease Outcomes Quality Initiative (K/DOQI) Advisory Board of the National Kidney Foundation, and the Quality and Patient Safety Task Force and Board of Advisors of the American Society of Nephrology. Dr Jaber has served on the Scientific Program Committee of the Annual Clinical Meetings of the National Kidney Foundation, and has previously directed its annual Hemodialysis Course. He has also served as co-editor for the American Journal of Kidney Diseases. He is the recipient of numerous awards and has authored more than 175 original publications, reviews and editorials in peer-reviewed scientific journals.